CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells

European Journal of Immunology

Volumn 30, Issue 4, 2000, Pages 1078-1087

  Monleón, Inmaculada ^a   Martínez Lorenzo, María José ^a   Anel, Alberto ^a   Lasierra, Pilar ^b   Larrad, Luis ^b   Piñeiro, Andrés ^a   Naval, Javier ^a   Alava, Maria A ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Activation induced cell death; APO2 ligand; CD59; Fas FasL; T lymphocyte; TRAIL

Indexed keywords

CD59 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GLYCOSYLPHOSPHATIDYLINOSITOL; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD59; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; CASPASE 3; CASPASES; CELL MEMBRANE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PHYTOHEMAGGLUTININS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTOR AGGREGATION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0342265112     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200004)30:4<1078::AID-IMMU1078>3.0.CO;2-Q     Document Type: Article

References (46)

1. Kerr, J. F. R., Wyllie, A. H. and Currie, A. R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972. 26: 239-257.
2. Steller, H., Mechanisms and genes of cellular suicide. Science 1995. 267: 1445-1449.
3. Russell, J. H., Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 1995. 7: 382-388.
4. Vignaux, F. and Golstein, P., Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 1994. 24: 923-927.
5. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
6. Dhein, J., Walczak, H., Bäumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 1995. 373: 438-441.
7. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995. 377: 348-351.
8. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. and Goodwin, R. G., Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995. 3: 673-682.
9. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A. and Ashkenazi, A., Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996. 271: 12687-12690.
10. Martínez-Lorenzo, M. J., Alava, M. A., Gamen, S., Kim, J. K., Chuntharapai, A., Piñeiro, A., Naval, J. and Anel, A., Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 1998. 28: 2714-2725.
11. Davies, A., Simons, D. L., Hale, G., Harrison, R. A., Tighe, H., Lachmann, P. J. and Waldmann, H., CD59, an Ly6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 1989. 170: 637-647.
12. Hahn, W. C., Menu, E., Bothwell, A. L. M., Sims, P. J. and Bierer, B. E., Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 1992. 256: 1805-1809.
13. Sandrin, M. S., Mouhtouris, E., Vaughan, H. A., Warren, H. S. and Parish, C. R., CD48 is a low affinity ligand for human CD2. J. Immunol. 1993. 151: 4606-4613.
14. Korty, P. E., Brando, C. and Shevach, E. M., CD59 functions as a signal-transducing molecule for human T cell activation. J. Immunol. 1991. 146: 4092-4099.
15. Deckert, M., Ticchioni, M., Mari, B., Mary, D. and Bernard, A., The glycosylphosphatidylinositol-anchored CD59 protein stimulates both T cell receptor/ZAP-70-dependent and -independent signaling pathways in T cells. Eur. J. Immunol, 1995. 25: 1815-1822.
16. Hueber, A. O., Raposo, G., Pierres, M. and He, H. T., Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism. J. Exp. Med. 1994. 179: 785-796.
17. Hueber, A. O., Bernard, A. M., Battari, C. L., Marguet, D., Massol, P., Foa, C., Brun, N., Garcia, S., Stewart, C., Pierres, M. and He, H. T., Thymocytes m Thy-1-/-mice show augmented TCR signaling and impaired differentiation. Curr. Biol. 1997. 7: 705-708.
18. Martinez-Lorenzo, M. J., Alava, M. A., Anel, A., Piñeiro, A. and Naval, J., Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 1996 89: 511-517.
19. Ohashi, P., Mak, T. W., Van den Elsen, P., Yanagi, Y., Yoshikai, Y., Calman, A. F., Stobo, J. D. and Weiss, A., Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer. Nature 1985. 316: 606-609.
20. Gamen, S., Marzo, I., Anel, A., Piñeiro, A. and Naval, J., CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS. Lett. 1996. 390: 233-237.
21. Salmerón, A., Sánchez-Madrid, F., Ursa, M. A., Fresno, M. and Alarcón, B., A conformational epitope expressed upon association of CD3-ε with either CD3-δ or CD3-γ is the main target for recognition by anti-CD3 monoclonal antibodies. J. Immunol. 1991. 147: 3047-3052.
22. Ashkenazi, A. and Dixit, V. M., Death receptors: Signaling and modulation. Science 1998. 281: 1305-1308.
23. Oyaizu, N., Than, S., McCloskey, T. W. and Pahwa, S., Requirement of p56lck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem. Biophys. Res. Commun. 1995. 213: 994-1001.
24. Lancki, D. W., Qian, D., Fields, P., Gajewski, T. and Fitch, F. W., Differential requirements for protein tyrosine kinase Fyn in the functional activation of antigen-specific T lymphocyte clones through the TCR or Thy-1. J. Immunol. 1995. 154: 4363-4370.
25. Xavier, R., Brennan, T., Li, Q., McCormack, C. and Seed, B., Membrane compartmentation is required for efficient T cell activation. Immunity 1998. 8: 723-732.
26. Zhang, W., Trible, R. P. and Samelson, L. E., LAT palmitoylation: Its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 1998. 9: 239-246.
27. Montixi, C., Langlet, C., Bernard, A. M., Thimonier, J., Dubois, C., Wurbel, M. A., Chauvin, J. P., Pierres, M. and He, H. T., Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 1998. 17: 5334-5348.
28. Stulnig, T. M., Berger, M., Sigmund, T., Raederstorff, D., Stockinger, H. and Waldhäusl, W., Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J. Cell Biol. 1998. 143: 637-644.
29. Wegener, A. M., Letourneur, F., Hoeveler, A., Brocker, T., Luton, F. and Malissen, B., The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 1992. 68: 83-95.
30. Jeremias, I., Herr, I., Boeheler, T. and Debatin, K. M., TRAIL/ Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 1998. 28: 143-152.
31. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P. and Ashkenazi, A., Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997. 277: 818-821.
32. Pan, G., Ni, J., Wei, Y. F., Yu, G. L., Gentz, R. and Dixit, V. M., An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997. 277: 815-818.
33. Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh, J. C. L and Lynch, D. H., Tumoricidal activity of TRAIL in vivo. Nature Med. 1999. 5: 157-163.
34. + T cell killing of target cells. J. Immunol. 1998. 161: 2195-2200.
35. Kayagaki, N., Yamaguchi, N., Nakayama, M., H., E., Okumura, K. and Yagita, H., Type I interferons (IFNs) regulate TRAIL expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 1999. 189: 1451-1460.
36. Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S. and Perussia, B., Natural killer cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 1998. 188: 2375-2380.
37. Griffith, T. S., Wiley, S. R., Kubin, M. Z., Sedger, L. M., Maliszewski, C. R. and Fanger, N. A., Monocyte-mediated tumoricidal activity via the TNF-related cytokine, TRAIL. J. Exp. Med. 1999. 189: 1343-1354.
38. Murray, E. W. and Robbins, S. M., Antibody cross-linking of the glycosylphosphatidylinositol-linked protein CD59 on hematopoietic cells induces signaling pathways resembling activation by complement. J. Biol. Chem. 1998. 273: 25279-25284.
39. Mollereau, B., Deckert, M., Déas, O., Rieux-Laucat, F., Hirsch, F., Bernard, A., Fischer, A., Lynch, D. H., Charpentier, B., Le Deist, F. and Senik, A., CD2-induced apoptosis in activated human peripheral T cells. A Fas-independent pathway that requires early tyrosine phosphorylation. J. Immunol. 1996. 156: 3184-3190.
40. Ida, H. and Anderson, P., Activation-induced NK cell death triggered by CD2 stimulation. Eur. J. Immunol. 1998. 28: 1292-1300.
41. Rowan, W., Tite, J., Topley, P. and Brett, S. J., Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells. Immunology 1998. 95: 427-436.
42. Marsters, S. A., Sheridan, J. P., Pitti, R. M., Brush, J., Goddard, A. and Ashkenazi, A., Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 1998. 8: 525-528.
43. Chinnayian, A. M., O'rourke, K., Yu, G. L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J. and Dixit, V. M., Signal transduction by DR3, a death domain-containing receptor related to TNFR1 and CD95. Science 1996. 274: 990-992.
44. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D., Abbot, B. J., Mayo, J. G., Shoemaker, R. H. and Boyd, M. R., Sensibility of drug screening with panels of human tumor cell lines using rnicroculture tetrazolium assay. Cancer Res. 1988. 46: 589-601.
45. Alava, M. A., DeBell, K. E., Conti, A., Hoffman, T. and Bonvini, E., Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/ CD3 complex but not by G-protein stimulation. Association with protein kinase A phosphorylation of phospholipase C-γ1. Biochem. J. 1992. 284: 189-199.
46. Martínez-Lorenzo, M. J., Gamen, S., Etxeberria, J., Lasierra, P., Larrad, L., Piñeiro, A., Anel, A., Naval, J. and Alava, M. A., Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemias. Int. J. Cancer 1998. 75: 473-481.